Bill Ackman's Pershing Square proposed to acquire 10 million newly issued Howard Hughes shares at $90 a share — up from $85 a ...

Bausch Health Cos. convinced a federal court to dismiss, for now, allegations that executives misled investors about the spin-off of Bausch + Lomb, and other corporate liabilities.

The actinic keratosis treatment market is expected to grow from USD 6.13 billion in 2024 to USD 12.28 billion by 2034, at a CAGR of 7.2%. Increasing concerns over skin cancer and advancements in ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...

BHC's fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.

The FDA has finally approved Valeant’s eye drug Vyzulta after the company finally satisfied the regulator’s concerns over its manufacturing facility in Florida. The Quebec-based company’s ...

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

The Varicella Zoster Infection Treatment Market is expected to grow from USD 1.5 billion in 2020 to USD 2.0 billion by 2028, with a CAGR of 4.1%. Acyclovir dominates the market, holding a 55.7% share ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.